|
000
| 01459nam 2200325za 4500 |
|---|
| 001 | 9.853884 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107154931 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 180319s2018 onc o f000 0 eng d |
|---|
| 020 | |a9780660258249 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH13-9/8-2018E-PDF |
|---|
| 245 | 00|aGuidance document |h[electronic resource] : |bpost‐notice of compliance (NOC) changes : framework document. |
|---|
| 246 | 30|aPost‐notice of compliance (NOC) changes : |bframework document |
|---|
| 246 | 17|aPost‐NOC changes : |bframework document |
|---|
| 260 | |aOttawa : |bHealth Canada, |c2018. |
|---|
| 300 | |a13 p. |
|---|
| 500 | |aIssued also in French under title: Ligne directrice : changements survenus après l'avis de conformité (AC) : document‐cadre. |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"Date adopted: 2009/09/02. Revised date: 2018/02/19. Effective date: 2018/08/27." |
|---|
| 500 | |a"Publication date: August 2018." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 693 | 4|aDrug approval |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 775 | 08|tLigne directrice |w(CaOODSP)9.853885 |
|---|
| 856 | 40|qPDF|s404 KB|uhttps://publications.gc.ca/collections/collection_2018/sc-hc/H13-9-8-2018-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/post-notice-compliance-changes/framework-document.html |
|---|